Iowa City Resident Cycling 270 Miles to End ALS

Cambridge, MA – This June, Lance Tillison will join approximately 400 men and women in the 13th annual Tri-State Trek, a three day, 270-mile charity bike ride with the mission to end amyotrophic lateral sclerosis (ALS).

ALS, also known as Lou Gehrig’s disease, is a progressive neurodegenerative disease that leads to paralysis, and the eventual death of those afflicted. At this moment, there are approximately 30,000 people in the US living with ALS, and the average patient survives only two to five years following his or her diagnosis.

This will be Tillison’s first time participating in the Tri-State Trek, and he plans to ride 270 miles and all three days of the event. “I’m riding to raise money and awareness for the fight against ALS. Through my humanitarian efforts, I hope to encourage and inspire others to join and/or support!“

All proceeds from the Tri-State Trek support the ALS Therapy Development Institute (www.ALS.net), the world’s first and largest nonprofit biotech focused 100 percent on ALS research. Tillison’s participation in the Tri-State Trek not only helps raise awareness for ALS, but also the research funds necessary to develop effective treatments, and ultimately a cure.

In the past twelve years, riders and volunteers of the Tri-State Trek have raised more than $6 million for the ALS Therapy Development Institute. With this support, the Institute has been able to move projects and partnerships forward toward the goal of ending ALS through research initiatives such as the completion of its Phase IIA clinical trial of Gilenya in ALS, the expansion of its Precision Medicine Program, and the acceleration (of the clinical development) of two potential treatments for ALS.

The 13th annual Tri-State Trek will take place June 26th-28th. To support Tillison’s efforts, please visit http://tst.als.net/lancetillison. For more information on riding, volunteering, or coming out to cheer, call 617-441-7200 or visit www.TriStateTrek.com.

About ALS Therapy Development Institute

The ALS Therapy Development Institute (ALS.net) and its scientists actively discover and develop treatments for Amyotrophic Lateral Sclerosis. ALS.net is the world’s first and largest nonprofit biotech focused 100% on ALS research. Led by patients and their families, the charity understands the urgent need to slow and stop this horrible disease. For more information, visit www.als.net.